Materia A, Pizzuto G, Silecchia G, Fiocca F, Fantini A, Spaziani E, Basso N
II Clinica Chirurgica, University La Sapienza, Rome, Italy.
Surg Laparosc Endosc. 1996 Aug;6(4):273-7.
Preoperative common bile duct (CBD) clearance with endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic sphincterotomy (ES) is routinely performed in many centers where laparoscopic cholecystectomy (LC) is the procedure of choice for the treatment of cholelithiasis. The purpose of this study was to evaluate prospectively the results of the sequential endoscopic-laparoscopic management in patients with gallstones and suspected CBD stones. From November 1990 to May 1993, 700 consecutive patients were evaluated for LC. Preoperative workup included clinical history and physical examination; serum levels of bilirubin, alkaline phosphatase, and amylase; and ultrasonography. Preoperative ERCP was indicated in cases with previous or present jaundice or acute pancreatitis, altered liver or pancreatic blood tests, dilated CBD (> 6 mm) and CBD stones at ultrasonography. If CDB pathology was confirmed, ES was performed and treatment attempted. All patients were assigned to undergo LC within 48 h. Morbidity, mortality, hospital stay, and disability were recorded. Of 700 patients, 49 (7%) underwent ERCP. In 26 patients (54.2%), CBD stones were identified; ES was performed and stone extraction succeeded in 22 patients (84.6%). Two patients with intrahepatic stones were successfully treated with a percutaneous transhepatic approach and then underwent surgery. Two patients with cholecystocholedochal fistula underwent open surgery. In two cases ERCP showed a papillary stenosis, which was treated with ES. Of 44 patients, 35 (79.5%) underwent LC within 48 h. The overall morbidity (ERCP/ES plus LC) was 10.4%. No mortality occurred. The mean hospital stay was 4.5 days. Return to normal activities occurred within 11 days after LC. This sequential approach resulted in a safe and effective treatment of cholecystocholedocholithiasis and a decrease in the overall costs.
在许多将腹腔镜胆囊切除术(LC)作为治疗胆结石首选术式的中心,常规采用内镜逆行胰胆管造影术(ERCP)和内镜括约肌切开术(ES)进行术前胆总管(CBD)清理。本研究的目的是前瞻性评估胆结石合并疑似CBD结石患者采用内镜-腹腔镜序贯治疗的效果。1990年11月至1993年5月,对700例连续患者进行了LC评估。术前检查包括临床病史和体格检查;血清胆红素、碱性磷酸酶和淀粉酶水平;以及超声检查。术前ERCP适用于既往或目前有黄疸或急性胰腺炎、肝脏或胰腺血液检查结果异常、超声显示CBD扩张(>6mm)及CBD结石的病例。如果确诊为CDB病变,则进行ES并尝试治疗。所有患者均被安排在48小时内接受LC。记录发病率、死亡率、住院时间和残疾情况。700例患者中,49例(7%)接受了ERCP。26例患者(54.2%)发现有CBD结石;进行了ES,22例患者(84.6%)成功取出结石。2例肝内结石患者经皮经肝途径成功治疗后接受了手术。2例胆囊胆总管瘘患者接受了开放手术。2例患者ERCP显示乳头狭窄,经ES治疗。44例患者中,35例(79.5%)在48小时内接受了LC。总体发病率(ERCP/ES加LC)为10.4%。无死亡病例。平均住院时间为4.5天。LC术后11天内恢复正常活动。这种序贯方法导致了胆囊胆总管结石的安全有效治疗,并降低了总体费用。